Malignant ascite-derived extracellular vesicles inhibit T cell activity by upregulating Siglec-10 expression

References

• Dinkelspiel HE, Champer M, Hou J, et al. Long-term mortality among women with epithelial ovarian cancer. Gynecol Oncol. 2015;138(2):421–428. doi:10.1016/j.ygyno.2015.06.00526050923
   PubMed Web of Science ®Google Scholar
• Wang M, Zhao J, Zhang L, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8:761–773. doi:10.7150/jca.1764828382138
   PubMed Web of Science ®Google Scholar
• Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121(1):1–14. doi:10.1111/imm.2007.121.issue-117386080
   PubMed Web of Science ®Google Scholar
• Stanske M, Wienert S, Castillo-Tong DC, et al. Dynamics of the intratumoral immune response during progression of high-grade serous ovarian cancer. Neoplasia. 2018;20(3):280–288. doi:10.1016/j.neo.2018.01.00729466768
   PubMed Web of Science ®Google Scholar
• Pogge von Strandmann E, Reinartz S, Wager U, et al. Tumor–host cell interactions in ovarian cancer: pathways to therapy failure. Trends Cancer. 2017;3(2):137–148. doi:10.1016/j.trecan.2016.12.00528718444
   PubMed Web of Science ®Google Scholar
• Sullivan R, Maresh G, Zhang X, et al. The emerging roles of extracellular vesicles as communication vehicles within the tumor microenvironment and beyond. Front Endocrinol (Lausanne). 2017;8:194. doi:10.3389/fendo.2017.0019428848498
   PubMed Web of Science ®Google Scholar
• Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27(3):172–188. doi:10.1016/j.tcb.2016.11.00327979573
   PubMed Web of Science ®Google Scholar
• Becker A, Thakur BK, Weiss JM, et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30(6):836–848. doi:10.1016/j.ccell.2016.10.00927960084
   PubMed Web of Science ®Google Scholar
• Cohen IJ, Blasberg R. Impact of the tumor microenvironment on tumor-infiltrating lymphocytes: focus on breast cancer. Breast Cancer (Auckl). 2017;11:1178223417731565.28979132
   PubMed Web of Science ®Google Scholar
• Nawaz M, Fatima F, Nazarenko I, et al. Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery. Expert Rev Proteomics. 2016;13(4):395–409. doi:10.1586/14789450.2016.116561326973172
   PubMed Web of Science ®Google Scholar
• Li Y, Yang Y, Xiong A, et al. Comparative gene expression analysis of lymphocytes treated with exosomes derived from ovarian cancer and ovarian cysts. Front Immunol. 2017;8:607. doi:10.3389/fimmu.2017.0060728620375
   PubMed Web of Science ®Google Scholar
• Macauley MS, Crocker PR, Paulson JC. Siglec regulation of immune cell function in disease. Nat Rev Immunol. 2014;14(10):653–666. doi:10.1038/nri373725234143
   PubMed Web of Science ®Google Scholar
• Liu YC, Yu MM, Chai YF, Shou ST. Sialic acids in the immune response during sepsis. Front Immunol. 2017;8:1601. doi:10.3389/fimmu.2017.0160129209331
   PubMed Web of Science ®Google Scholar
• Zhao Y, Su H, Shen X, et al. The immunological function of CD52 and its targeting in organ transplantation. Inflamm Res. 2017;66(7):571–578. doi:10.1007/s00011-017-1032-828283679
   PubMed Web of Science ®Google Scholar
• Zhang P, Lu X, Tao K, et al. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. J Surg Res. 2015;194(1):107–113. doi:10.1016/j.jss.2014.09.03525450598
   PubMed Web of Science ®Google Scholar
• Yamamoto CM, Oakes ML, Murakami T, et al. Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers. J Ovarian Res. 2018;11(1):20. doi:10.1186/s13048-018-0391-229499737
   PubMedGoogle Scholar
• Yokoi A, Yoshioka Y, Yamamoto Y, et al. Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer. Nat Commun. 2017;8:14470. doi:10.1038/ncomms1447028262727
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhang J, Li X, et al. Protein microarray analysis identifies key cytokines associated with malignant middle cerebral artery infarction. Brain Behav. 2017;7(8):e00746. doi:10.1002/brb3.74628828208
   PubMed Web of Science ®Google Scholar
• Cornfield DB, Gheith SM. Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions. Cytometry B Clin Cytom. 2009;76(3):213–217. doi:10.1002/cyto.b.2045518803280
   PubMedGoogle Scholar
• Aherne SA, O’Brien NM. Modulation of cytokine production by plant sterols in stimulated human Jurkat T cells. Mol Nutr Food Res. 2008;52(6):664–673. doi:10.1002/mnfr.20070038518465778
   PubMed Web of Science ®Google Scholar
• Bartis D, Boldizsár F, Szabó M, et al. Dexamethasone induces rapid tyrosine-phosphorylation of ZAP-70 in Jurkat cells. J Steroid Biochem Mol Biol. 2006;98(2–3):147–154. doi:10.1016/j.jsbmb.2005.01.03216406604
   PubMed Web of Science ®Google Scholar
• Chen GY, Tang J, Zheng P, et al. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science. 2009;323(5922):1722–1725. doi:10.1126/science.116898819264983
   PubMed Web of Science ®Google Scholar
• O’Loghlen A. Role for extracellular vesicles in the tumour microenvironment. Philos Trans R Soc Lond B Biol Sci. 2018;373(1737):20160488. doi:10.1098/rstb.2017.007229158316
   PubMedGoogle Scholar
• Greening DW, Gopal SK, Xu R, Simpson RJ, Chen W. Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol. 2015;40:72–81. doi:10.1016/j.semcdb.2015.02.00925724562
   PubMed Web of Science ®Google Scholar
• Vanichapol T, Chutipongtanate S, Anurathapan U, Hongeng S. Immune escape mechanisms and future prospects for immunotherapy in neuroblastoma. Biomed Res Int. 2018;2018:1812535. doi:10.1155/2018/181253529682521
   PubMed Web of Science ®Google Scholar
• Junker K, Heinzelmann J, Beckham C, Ochiya T, Jenster G. Extracellular vesicles and their role in urologic malignancies. Eur Urol. 2016;70(2):323–331. doi:10.1016/j.eururo.2016.02.04626924769
   PubMed Web of Science ®Google Scholar
• D’Asti E, Chennakrishnaiah S, Lee TH, Rak J. Extracellular vesicles in brain tumor progression. Cell Mol Neurobiol. 2016;36(3):383–407. doi:10.1007/s10571-015-0296-126993504
   PubMed Web of Science ®Google Scholar
• Zaborowski MP, Balaj L, Breakefield XO, Lai CP. Extracellular vesicles: composition, biological relevance, and methods of study. BioScience. 2015;65(8):783–797. doi:10.1093/biosci/biv08426955082
   PubMed Web of Science ®Google Scholar
• Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113(1):1–11. doi:10.1007/s11060-013-1084-823456661
   PubMed Web of Science ®Google Scholar
• Aguilar-Mahecha A, Hassan S, Ferrario C, Basik M. Microarrays as validation strategies in clinical samples: tissue and protein microarrays. OMICS. 2006;10(3):311–326. doi:10.1089/omi.2006.10.31117069510
   PubMed Web of Science ®Google Scholar
• Al Kuraya K, Simon R, Sauter G. Tissue microarrays for high-throughput molecular pathology. Ann Saudi Med. 2004;24(3):169–174. doi:10.5144/0256-4947.2004.16915307452
   PubMed Web of Science ®Google Scholar
• Bandala-Sanchez E, Zhang Y, Reinwald S, et al. T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10. Nat Immunol. 2013;14(7):741–748. doi:10.1038/ni.261023685786
   PubMed Web of Science ®Google Scholar